Elevated proα2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene  by Kähäri, Veli-Matti et al.
Volume 215, number 2, 331-334 FEB 04695 May 1987 
Elevated proa2(1) collagen mRNA levels in cultured 
scleroderma fibroblasts result from an increased 
transcription rate of the corresponding ene 
Veli-Matti Klhiri, Petteri Multimlki and Eero Vuorio 
Department of Medical Chemistry, University of Turku, Kiinamyllynkatu 10. SF-20520 Turku, Finland 
Received 9 March 1987 
Fibroblasts cultured from affected and unaffected skin sites of three scleroderma patients were studied for 
the activation of type I collagen gene expression. Dot blot hybridizations with proa2(1) collagen specific 
cDNA probe revealed 2.9-4.8-fold increases in proa2(1) mRNA levels in the affected fibroblasts over the 
unaffected control cells. Transcription rate of the proa2(1) gene in the nuclei isolated from the same cells 
was 2.0-3.7-fold higher in the scleroderma fibroblasts than in the controls. The results how that seleroder- 
ma fibroblasts have undergone activation of collagen gene xpression atthe transcriptional level, which sub- 
sequently results in elevated procollagen mRNA levels, overproduction of collagen, and development of 
dermal fibrosis. 
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1. INTRODUCTION 
Collagen is the main constituent of the ex- 
tracellular matrix. Although the complicated 
biosynthesis of collagen provides many levels for 
possible control mechanisms [l], most of the cur- 
rent information suggests that collagen gene ex- 
pression is regulated by modulating cellular 
mRNA levels. Correlation between collagen pro- 
duction and procollagen mRNA levels has been 
found in a number of developmental and ex- 
perimental models [2-61. On the other hand, 
translational control of collagen synthesis has also 
been reported [7,8]. In vitro transcription ex- 
periments have shown that cellular procollagen 
mRNA levels are mainly regulated at the transcrip- 
tional level [9,10], but modulation of mRNA 
degradation rates appears to be another regulatory 
step in collagen gene expression [ 111. 
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Localized scleroderma is a fibrotic disorder 
characterized by excessive accumulation of col- 
lagen in skin. Cell culture studies have shown that 
fibroblasts cultured from scleroderma lesions pro- 
duce increased amounts of type I and III collagen 
when compared to control fibroblasts [12,13]. We 
and others have shown that cultured scleroderma 
fibroblasts exhibit elevated cellular mRNA levels 
of type I and III collagen [14-171 to account for 
the increased collagen production. The purpose of 
this work was to extend these studies to measure- 
ment of the transcription rate of type I collagen 
genes in scleroderma fibroblasts. Our results show 
that collagen gene expression is activated at the 
level of transcription in scleroderma, suggesting an 
important role for factors involved in the regula- 
tion of the promoter regions of these genes. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
Fibroblast cultures were started by explantation 
from affected and symmetrically located unaf- 
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fected skin sites of three female patients, aged 9 
(PAH), 13 (KLU) and 51 (JAL), with histological- 
ly confirmed localized scleroderma. For the 
analyses, early passage cultures were grown to con- 
fluence in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum 
(Hazleton, Denver, PA), and incubated with 
50 pg/ml ascorbate for 24 h prior to isolation of 
nuclei. 
2.2. Nuclear run-off transcriptions 
Isolation of nuclei was carried out as described 
1181. Aliquots were stained with trypan blue for 
determination of the number of nuclei. For 
transcription, aliquots of 1 x lo6 nuclei were in- 
cubated in a lOO-~1 reaction containing 16% 
glycerol, 20 mM Tris-HCl, pH 8.0, 2 mM Mg 
acetate, 2.5 mM dithiothreitol, 5 mM MgC12, 
100 mM KCl, 1 mM each ATP, GTP, UTP, 
125 $Zi [a-32P]CTP (3000 Ci/mmol, Amersham, 
England) and 1 U/p1 human placental RNase in- 
hibitor, RNasin@ (Promega Biotec, Madison, WI) 
for 45 min at 26°C. The overall incorporation of 
[32P]CTP into RNA transcripts was estimated by 
precipitating l-p1 aliquots with cold 10% 
trichloroacetic acid and determining the radioac- 
tivity of the precipitates by liquid scintillometry. 
Transcription reactions were terminated by in- 
cubation with lOrg/ml of DNase I (Boehringer 
Mannheim, FRG) for 5 min at 26°C. Thereafter 
50pg/ml of yeast tRNA was added for carrier. 
Radiolabeled RNA was isolated as described 
[19], dissolved in 10 mM Tris-HCl, pH 7.5, 1 mM 
EDTA, 0.1% SDS and denatured by heating at 
65°C for 15 min. Equal amounts of radioactivity 
were hybridized to 2-pg aliquots of non-radioactive 
plasmid DNA immobilized to nitrocellulose filters 
[20]. Hybridization and washing of the filters were 
carried out as described by Thomas [21]. The 
filters were exposed to Kodak X-Omat film at 
- 70°C using intensifying screens. The intensity of 
hybridization was quantified by densitometry. 
2.3. Measurement of type I procollagen mRNA 
levels 
Cytoplasmic RNA was isolated from fibroblasts 
as described earlier [22]. Aliquots were applied to 
nitrocellulose filters, immobilized and prehybrid- 
ized 1211. The filters were hybridized with plasmid 
pHCAL2, which contains an 1180 bp cDNA se- 
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quence specific for human procu2(1) collagen 
mRNA [17]. Plasmid DNA was nick-translated 
with [a-32P]dCTP to a specific activity of approx. 
5 x 10’ cpm/pg, hybridized and washed as describ- 
ed above. Hybridization was detected and quan- 
tified as above. 
3. RESULTS 
Estimation of procu2(1) collagen mRNA levels by 
cytoplasmic dot blot hybridizations revealed 
2.9-4.8-fold increases in prm2(1) collagen mRNA 
levels in the three affected scleroderma fibroblast 
lines compared to their unaffected controls (fig.1). 
The incorporation of [32P]CTP into nuclear run- 
off transcripts increased up to 45 min (fig.2). Total 
JAL PAU KLU 
Fig.1. Cytoplasmic procu2(1) collagen mRNA levels in 
fibroblasts cultured from affected (hatched bar) and 
unaffected (open bar) skin sites of scleroderma patients 
JAL, PAH and KLU. Prau2(1) mRNA levels were 
measured by dot blot hybridizations and quantified 
densitometrically. 
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Fig.2. Incorporation of [32P]CTP into the trichloroace- 
tic acid precipitable nucleic acids in nuclei isolated from 
affected (0) and unaffected (0) skin fibroblasts of 
scleroderma patients JAL (A) and PAH (B). Nuclei were 
isolated from confluent fibroblast cultures and run-off 
transcriptions were carried out in the presence of 
[3ZP]CTP. Aliquots taken at the time points indicated 
were precipitated with cold 10% trichloroacetic acid and 
the radioactivity of precipitates determined with liquid 
scintillometry. 
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[32P]CTP incorporation was somewhat higher in 
nuclei isolated from affected fibroblasts of patient 
JAL compared to unaffected fibroblasts (fig.2A). 
Only slight differences were detected in [3zP]CTP 
incorporation between nuclei from scleroderma 
and control fibroblasts of patient PAH (fig.2B). 
Hybridization of the labeled nuclear RNA to 
plasmids pHCAL2 and pBR322 immobilized onto 
nitrocellulose filters (fig.3) revealed 2.0-3.7-fold 
increases in the transcription rate of the procu2(1) 
collagen gene in the nuclei from scleroderma 
fibroblasts compared to unaffected controls 
(fig.4). The results were reproducible in two in- 
Fig.3. Transcription of procu2(1) collagen gene in lo6 
nuclei isolated from affected (1) and unaffected 
fibroblasts (2) of scleroderma patients JAL, PAH and 
KLU. Transcriptions were performed for 45 min in the 
presence of [32P]CTP and the labeled RNAs were 
isolated. 2-pg aliquots of plasmid DNA containing an 
insert specific for human procu2(1) collagen mRNA 
(pHCAL2) and of plasmid pBR322 (negative control) 
were denatured and dotted onto nitrocellulose filters. 
After hybridization and washing, the filters were 
exposed to X-ray films. The results of two different 
exposures are shown for each of the three cell line pairs. 
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Fig.4. Transcription rate of procr2(1) collagen gene in 
nuclei isolated from affected (hatched bar) and 
unaffected (open bar) fibroblasts of three scleroderma 
patients (JAL, PAH and KLU). The mean and SE of 
2-3 exposures from two transcriptions are indicated. 
dependent ranscription assays. No hybridization 
of the labeled transcripts to plasmid pBR322 could 
be detected. 
4. DISCUSSION 
The capacity of fibroblasts cultured from pro- 
gressing scleroderma lesions to produce increased 
amounts of collagen has been well documented 
[ 12,131. A correlation between increased collagen 
synthesis and elevated procollagen mRNA levels in 
scleroderma fibroblasts has been reported [ 14- 171. 
In this study we show that fibroblasts cultured 
from affected skin sites of scleroderma patients ex- 
hibit increased transcription rates of the procu2(1) 
collagen gene to account for the elevated levels of 
the corresponding mRNA in these cells. Due to 
technical difficulties only the levels of procu2(1) col- 
lagen transcripts could be reliably determined, but 
all the information available suggests a strict con- 
trol of the (~1 :CY~ ratio in fibroblasts [17,23]. An 
alteration in the degradation rate of procollagen 
mRNAs is another way to regulate the cellular 
levels of these mRNAs [Ill. Our results suggest, 
however, that the major mechanism responsible 
for increased procollagen mRNA levels in 
scleroderma is the increased transcription rate of 
the corresponding genes. 
The fact that the activation of collagen synthesis 
in scleroderma fibroblasts disappears in culture 
within 5-10 subcultures, suggests that stimulatory 
factors present in situ, but not in cell culture, play 
an important role in the activation process 
[ 15,17,24]. In order to characterize these factors, it 
is important to determine the level of activation of 
collagen gene expression. Recently, the role of 
polypeptide growth factors and proto-oncogenes 
in the activation of connective tissue formation has 
been emphasized 1251, although little is known of 
their exact role in the activation of collagen gene 
expression. The data available on transforming 
growth factor-p (TGF-fl indicate that this factor is 
a potent stimulator of collagen production both in 
vivo and in culture [26]. Transfection studies with 
NIH 3T3 cells have shown that certain viral on- 
cogene products can regulate the promoters of 
procrl(III) collagen gene [27] and prm2(1) collagen 
gene [28]. We feel that scleroderma provides a 
good model for studying molecular mechanisms of 
collagen overproduction in human fibrotic condi- 
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tions. The elucidation of the underlying 
pathogenetic mechanisms in these disorders re- 
quires studies on the expression of various growth 
factors and proto-oncogene products, their effects 
on collagen production, and analyses of factors in- 
teracting with promoter regions of collagen genes. 
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